Gregory P Swanson

Author PubWeight™ 16.63‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Prognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: a retrospective study. Lancet Oncol 2011 4.50
2 Validation of a cell-cycle progression gene panel to improve risk stratification in a contemporary prostatectomy cohort. J Clin Oncol 2013 4.04
3 Adjuvant androgen deprivation for high-risk prostate cancer after radical prostatectomy: SWOG S9921 study. J Clin Oncol 2011 2.57
4 Preradiation chemotherapy with methotrexate, cisplatin, 5-fluorouracil, and leucovorin for pediatric nasopharyngeal carcinoma. Cancer 2005 1.03
5 Tumor cytoreduction results in better response to androgen ablation--a preliminary report of palliative transurethral resection of the prostate in metastatic hormone sensitive prostate cancer. Urol Oncol 2010 0.92
6 Report from the Radiation Therapy Committee of the Southwest Oncology Group (SWOG): Research Objectives Workshop 2008. Clin Cancer Res 2009 0.86
7 Biased hormonal therapy duration analysis makes results uninterpretable. J Clin Oncol 2009 0.80
8 High-grade prostate cancer: favorable results in the modern era regardless of initial treatment. ISRN Oncol 2012 0.77
9 Report from the Radiation Oncology Committee of the Southwest Oncology Group (SWOG): Research Objectives Workshop 2003. Am J Clin Oncol 2003 0.76
10 Re: Risk-reduction mastectomy: clinical issues and research needs. J Natl Cancer Inst 2002 0.75
11 Local and systemic therapy for patients with metastatic prostate cancer: should the primary tumor be treated? Curr Urol Rep 2005 0.75